Bausch & Lomb (NYSE: BOL) is introducing two new soft gel versions of its patented eye health nutritional supplement, PreserVision(R), of which the AREDS formula has been clinically proven to battle the leading cause of severe vision loss among Americans aged 65 and older - age-related macular degeneration.
PreserVision Soft Gels AREDS Formula is an easy-to-swallow supplement designed to be taken twice a day while delivering the same levels of vitamins and minerals and all of the health benefits as the original four-tablet-a-day formula.
In that study, those who were at the highest risk for developing advanced age-related macular degeneration lowered their risk by about 25 percent when treated with the unique high-potency vitamin and mineral supplement contained in the Bausch & Lomb PreserVision AREDS supplement.
In a follow-up study, AREDS researchers estimate that more than 300,000 people most at risk would avoid advanced AMD and its associated vision loss over the next five years if they received high-dose antioxidant and zinc supplements such as those used in the AREDS trials.
About Bausch & Lomb PreserVision(R) AREDS Eye Vitamins